Dr. Debra M. Prow
Claim this profileMcFarland Clinic PC - Ames
Expert in Lung Cancer
Expert in Breast Cancer
125 reported clinical trials
185 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 positive
ER positive
Affiliated Hospitals
Clinical Trials Debra M. Prow is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
More about Debra M. Prow
Clinical Trial Related6 years of experience running clinical trials · Led 125 trials as a Principal Investigator · 47 Active Clinical TrialsTreatments Debra M. Prow has experience with
- Nivolumab
- Carboplatin
- Pembrolizumab
- Atezolizumab
- Ipilimumab
- Paclitaxel
Breakdown of trials Debra M. Prow has run
Lung Cancer
Breast Cancer
Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Debra M. Prow specialize in?
Debra M. Prow focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Debra M. Prow currently recruiting for clinical trials?
Yes, Debra M. Prow is currently recruiting for 47 clinical trials in Ames Iowa. If you're interested in participating, you should apply.
Are there any treatments that Debra M. Prow has studied deeply?
Yes, Debra M. Prow has studied treatments such as Nivolumab, Carboplatin, Pembrolizumab.
What is the best way to schedule an appointment with Debra M. Prow?
Apply for one of the trials that Debra M. Prow is conducting.
What is the office address of Debra M. Prow?
The office of Debra M. Prow is located at: McFarland Clinic PC - Ames, Ames, Iowa 50010 United States. This is the address for their practice at the McFarland Clinic PC - Ames.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.